Reinhold Schmieding and Arthrex: Company Overview
Reinhold Schmieding is the founder and controlling shareholder of Arthrex, a private medical device company focused on orthopedic implants, surgical instruments, and sports medicine products. Arthrex is headquartered in Naples, Florida, and supplies products to hospitals, ambulatory surgery centers, and orthopedic practices worldwide. The company is consistently ranked among the largest privately held medical device firms in the United States.
Reinhold Schmieding founded Arthrex in 1981 after working with small instruments and implants in orthopedic surgery. The company grew from a single product concept into a global supplier of arthroscopic and sports medicine devices. Arthrex remains privately held, with Reinhold Schmieding retaining majority ownership and serving as the primary decision maker on strategy, R&D investment, and long term growth.
Reinhold Schmieding Net Worth and Ownership
Reinhold Schmieding's net worth is estimated in the billions based on Arthrex's private valuation, revenue growth, and his controlling ownership stake. Forbes and other trackers list him among the wealthiest self made founders in the medical device sector. His wealth is tied directly to the company's performance rather than public stock market fluctuations.
Arthrex is controlled by Reinhold Schmieding and members of his family, with the company structured to maintain private ownership while funding global expansion. The firm reinvests a large share of revenue into research and development, manufacturing facilities, and new product lines. Arthrex has expanded production capacity in recent years to meet rising demand for orthopedic and sports medicine implants.
Arthrex Products, Markets, and Financial Position
Product Portfolio and Clinical Focus
Arthrex manufactures implants, sutures, anchors, shavers, and instruments used in knee, shoulder, ankle, and hip procedures. The company emphasizes minimally invasive surgical tools and arthroscopic techniques that reduce recovery time for patients. Arthrex also develops training programs and educational resources for orthopedic surgeons.
Revenue and Market Reach
Arthrex generates several billion dollars in annual revenue, with a large share coming from the United States and growing international markets. The company supplies hospitals and distributors in North America, Europe, and Asia, and has expanded direct sales teams in key regions. Arthrex continues to invest in new product development and manufacturing to support demand for orthopedic procedures.
For background on private medical device company valuations and industry trends, see the latest coverage on Forbes at https://www.forbes.com. For information on orthopedic device regulation and market structure, see the U.S. Food and Drug Administration at https://www.fda.gov.
